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Abstract Extensive studies of the MC4R gene polymor-
phism showed that, among numerous variants, there are
mutations responsible for monogenic obesity, as well as
polymorphisms negatively correlated with the risk of obesity.
In this report, we present the first studies of the whole coding
sequence of the MC4R gene in 243 Polish obese children and
adolescents (the mean relative body mass index [RBMI] was
163.6). In addition, 101 non-obese adults were also analyzed.
Direct sequencing facilitated the identification of six mis-
sense (K73R, V103I, T112M, S127L, M215L, and I251L)
and one silent (c.756 C>T) single-nucleotide polymorphisms
(SNPs). Two non-synonymous polymorphisms (K73R and
M215L) appeared to be novel and one was found in obese
patients (M215L, one patient) and one in non-obese adults
(K73R, one person). The overall frequency of non-
synonymous variant carriers reached 4.1% and 6.9% in
obese patients and non-obese adults, respectively. Only one
obesity-associated variant (127L) was found in two obese
patients (0.82%) and in two non-obese adults (1.98%). The
obesity-protecting variants (103I and 251L) appeared to be
the most common in both groups: 3.3% and 4.0%,
respectively. It was also observed that the RBMI in obese
children and adolescents carrying the minor variants did not
differ significantly from the non-carriers; however, the
expected trends for the associated and protecting variants
were observed. We conclude that the contribution of the
MC4R gene variants to the pathogenesis of obesity in Polish
children and adolescents is low.
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Introduction
It is well known that the monogenic form of obesity is
mainly caused by mutations of the MC4R gene (Santini et
al. 2009;T a o2009). There are over 150 variants of this
gene described, but their causality varies and, usually, they
are classified into five classes, in relation to their molecular
effects (Tao 2009): class 1, truncated receptor with a loss of
function; class 2, intracellular retention of the receptor
presenting normal length; class 3, altered binding function
of the receptor; 4, ligand binds the receptor but signal
transduction is altered; and type 5, lack of the deleterious
effect or the effect was not yet studied. Interestingly, there
are also two MC4R variants which are negatively correlated
with the risk of obesity (Stutzmann et al. 2007; Wang et al.
2010). These polymorphisms cause amino acid substitu-
tions in codon 103 (valine>isoleucine, V103I) and codon
251 (isoleucine>leucine, I251L).
The occurrence of the MC4R gene mutations causing
obesity was studied in different populations and different
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found that, in patients with an early-onset obesity, the
incidence of the carriers varies from less than 1% among
the Italian and Belgian populations to over 5% in the
UK population. A recent study of Belgian obese children
revealed the presence of 11 mutations, including two
novel ones, where the mutation carrier frequency was
5.6% (Beckers et al. 2010). In obese adults, the frequency
falls within the range from less than 1% (United
Kingdom, Japan, Germany, etc.) to 5% (Switzerland).
Obesity is a serious health problem also in Poland and the
frequency of overweight and obesity in children and
adolescents reaches 18.7% and 14.1% for boys and girls,
respectively, with a significant increase among boys at
younger ages if compared to the previous decade (Kułaga
et al. 2010).
Taking into consideration the major role of the MC4R
gene mutations in the pathogenesis of monogenic obesity
and the lack of knowledge on their distribution in the Polish
population, we decided to search for variants in the coding
sequence of this gene in a cohort of obese Polish children
or adolescents. Moreover, a group of non-obese adults was
also analyzed.
Materials and methods
Patients
Altogether, 344 blood samples (243 from obese subjects
and 101 non-obese adults) were collected from patients of
the Department of Pediatric Diabetes and Obesity, Poznan
University of Medical Sciences, Poznan, Poland. Each
patient was assigned to one of two groups: obese children
and adolescents (relative body mass index [RBMI]>120)
or non-obese adults (body mass index [BMI]<25) with no
obesity episodes in their lifetime (healthy individuals, age
range: 35–45 years). Unfortunately, a control group of
non-obese children and adolescents was not included in
this study and, thus, we assumed that non-obese adults
may play, to some extent, a role as the control group. In
the group of obese children and adolescents (119 girls and
124 boys), the following parameters were recorded: age,
sex, total body mass, and height. The RBMI (relative
BMI) was estimated by dividing the current BMI of every
obese patient by the ideal (50th percentile) BMI for their
age and gender and multiplying the obtained result by 100
(Cole et al. 2005). In the cohort of obese subjects (age
range: 4–17 years, average age: 12.4±3.8 years), the
average RBMI was 163.6±22.9. The study was approved
by the local Bio-Ethics Committee at the Poznan University
of Medical Sciences.
Methods
DNA was isolated from blood samples using a Blood Mini
isolation kit (A&A Biotechnology, Poland) according to the
manufacturer’s protocol. The coding region of the MC4R
gene was polymerase chain reaction (PCR)-amplified as
two fragments (536 and 708 bp, respectively). The PCR
primers (MC4R1F: 5′atcaattcagggggacactg, MC4R1R: 5′
ccaacccgcttaactgtcat, MC4R2F: 5′gtagctccttgcttgcatcc,
MC4R2R: 5′acggaagagaaagctgttgc) were designed accord-
ing to the reference sequence deposited in the GenBank
(NC_000018.9) and generated with the use of the Primer3
tool (http://frodo.wi.mit.edu/primer3/). For both amplified
fragments, the following PCR conditions were applied: 95°C,
10 min (preliminary denaturation); 35 cycles of: denaturation
95°C, 30 s, annealing 60°C, 30 s, elongation 72°C, 30 s, and
72°C, 10 min (final synthesis). PCR was run in a
Biometra TGradient thermocycler (Biometra, Germany)
using Allegro Taq polymerase (Novazym, Poland).
Amplified fragments of the MC4R gene were screened
for polymorphisms using the direct sequencing method
(ABI Prism 3130 automatic sequencer, Applied Biosystems,
USA). For statistical analysis, the R package was applied
(version 2.12.0) (http://www.r-project.org/).
Polymorphic variant frequencies between slim and obese
subjects were compared with the use of Fisher’s exact test.
We also measured the significance of differences in the
average RBMI values between obese carriers of various
MC4R variants versus non-carriers, using the Wilcoxon
rank-sum test. The comparison was performed for each
polymorphic variant, as well as for three variant groups:
obesity-associated, obesity-protective, and variants with
unknown or unclear function. The groups were formed
according to the present knowledge on the variant
functionality.
Results
Altogether, 17 carriers of the non-synonymous MC4R gene
variants were found in the studied cohort (Table 1). To our
knowledge, among the six identified missense substitutions,
two were novel, i.e., c.218A>G and c.643A>T (Fig. 1),
causing K73R and M215L amino acid substitutions,
respectively. The other variants described in our study were
already reported earlier in other populations. The effect of
four known variants could be classified, according to Tao
(2009), to the following classes: 2 (S127L) and 5 (V103I,
T112M, and I251L). Two novel variants (K73R and
M215L) with unknown function represented class 5. In
addition, one obese patient was a carrier of the synonymous
polymorphism (c.756 C>T).
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obese subjects did not show any significant differences
(Table 1). However, the observed frequency tendencies
appeared to be unexpected in case of some variants. When
all of the non-synonymous variants were considered, the
frequency of the carriers among the obese subjects was
lower (4.1%) than in the controls (6.9%). Among the
identified substitutions, only one variant (127L) was
associated with obesity. The frequency of its carriers was
lower among obese patients (0.82%) than in the control
subjects (1.92%). The V103I polymorphism was the most
widely distributed and the incidence of the obesity-
protective variant (103I) carriers was only slightly smaller
in the obese patients (2.46%) than in non-obese adults
(2.97%). A similar trend was recorded for the other variant
protecting against obesity (251L), found in 0.82% of obese
subjects and 0.99% of non-obese adults. Two obese patients
were carriers of two polymorphic variants, the obesity-
associated (127L) and obesity-protective (103I) ones.
The RBMI in obese subjects (n=243) was 163.6. We
compared this parameter among the carriers (n=10) and
non-carriers (n=233) for the identified variants (Table 2).
The differences were not significant; however, some tenden-
cies were observed. In case of the obesity-associated variant
(127L), a higher mean RBMI was observed in the carriers
(177.5, n=2) than in the non-carriers (163.5, n=241). A
comparison of the obesity-protective variants (103I and
251L) revealed lower RBMI in the carriers (159.7, n=8)
than in the non-carriers (163.7, n=235). Two carriers of the
neutral variant (112M) or variant with unknown effect
(215L) had slightly higher mean RBMI (166.5, n=2) than
the non-carriers (163.6, n=241).
Discussion
Our main concern was focused on variants causing or
associated with obesity. We found only one such variant
(127L) which affects the function of the encoded receptor.
Two carriers of this variant, found in the studied cohort of
obese patients, showed that their mean RBMI was higher
than in non-carriers, as one could expect, but the difference
was not significant. Functional analysis of the 127L variant
Table 1 Distribution of non-synonymous MC4R polymorphism carriers in obese Polish children and adolescents, in comparison with a group of
non-obese adults
SNP
a Codon change Amino acid
position
Amino acid
change
Variant class
b Obese subjects
(n=243)
Non-obese adults
(n=101)
c.218A>G AAG>AGG 73 K>R uc
c – 1 (0.99%)
c.307 G>A GUC>AUC 103 V>I 5 6 (2.46%) 3 (2.97%)
c.335 C>T ACG>AUG 112 T>M 5 1 (0.41%) 2 (1.98%)
c.380 C>T UCG>UUG 127 S>L 2 2 (0.82%) 2 (1.98%)
c.643A>T AUG>UUG 215 M>L uc
c 1 (0.41%) –
c.751A>C AUU>CUU 251 I>L 5 2 (0.82%) 1 (0.99%)
All variants 10* (4.1%) 7** (6.9%)
Obesity-protective variants (103I and 251L) 8 (3.3%) 4 (4.0%)
Obesity-associated variant (127L) 2 (0.82%) 2 (1.98%)
Neutral variants or variants with unknown effect (73R, 112M, and 215L) 2 (0.82%) 3 (2.97%)
aAlso, one silent substitution c.756 C>T was identified in an obese subject;
bAccording to Tao (2009)
cUnclassified
*Two patients carried two SNPs (103I and 127L)
**Two adults carried two SNPs (103I and 127L)
Fig. 1 Novel variants of the MC4R gene causing amino acid
substitutions: a c.218A>G, K73R; b c.643A>T, M215L
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was found that the encoded receptor demonstrates an
impaired response to α-MSH (a natural agonist for
MC4R). However, the cell surface expression of the
receptor was not altered. These authors also calculated that
over 80% of all MC4R mutations associated with childhood
obesity can be caused by the intracellular retention of the
receptor. In our study, the frequency of this variant was
lower in the obese patients (0.82%) than in a group of 101
non-obese adults (1.98%). However, it should be pointed
out that the studied cohort of obese children and adoles-
cents was rather small (n=243). In another study, per-
formed by Santoro et al. (2009), comprising a cohort of 240
obese Italian children, three obesity-associated mutations
(S127L, Q307X, and Y332H) were found. The obesity
variant (127L) was found in three subjects (1.25%), thus,
the frequency was similar to our results. For these patients,
also, their family members were investigated and it was
shown that the mutation co-segregates with obesity. This
mutation was also found in Czech obese children, but its
frequency was very low (0.34%), while the total frequency
of the MC4R gene mutations in this cohort reached 2.4%
(Hainerová et al. 2007).
We identified two novel missense substitutions (K73R
and M215L). Unfortunately, we were not able to analyze
the effect of these mutations on the receptor functionality.
The variants were found in one obese patient (215L) and in
one non-obese adult (73R). Both amino acid substitutions
are located in the cytoplasmatic topological domain and
they do not change significantly the character of the amino
acids. In the first mutation, arginine as well as lysine belong
to the polar amino acids, while in the other mutation,
methionine and leucine are the non-polar amino acids.
Two obesity-protective variants were the most frequently
observed in both cohorts. This observation is in agreement
with other studies. In a recent study of 291 obese Dutch
children, 23 variants in the coding as well as 5′ flanking and
3′ UTR sequences of the MC4R gene were identified (van
den Berg et al. 2011). Six of them were localized in the 5′
flanking region (four in the 5′ UTR), 11 in the coding
sequence, and two in the 3′ UTR. The minor allele
frequency (MAF) ranged from 0.0017 to 0.35. For the
most common polymorphisms, considered as obesity-
protective variants, V103I and I251L, the MAF amounted
to 0.01 (103I) and 0.0017 (251L), respectively. In our
study, the MAF values were similar: 0.013 for 103L and
0.004 for 251L. A similar trend for the V103I polymor-
phism was obtained from the meta-analysis, where the
frequency of the 103I variant carriers was 2.9% in obese
(n=19,882) and 3.9% in non-obese (n=35,373) subjects
(Wang et al. 2010). In that study, the authors gathered data
from previously published papers and concluded that,
among obese patients, the incidence of the 103I variant
carriers varied from less than 0.1% (Italy) and 0.6%
(Germany and Finland) to almost 20% (Turkey). In non-
obese subjects, the incidence of the carriers varied from 0%
(Germany), 1% to 3.3% (Italy), 2.8% (Finland), up to 9%
(Turkey). Recently, the V103I polymorphism was also
studied in a cohort of 311 Polish adults (mean BMI=27) in
relation to their physical activity (Jóźków et al. 2011). The
incidence of the 103I variant carriers was high (6.4%) and,
in addition, one patient (0.3%) had a homozygous 103I/
103I genotype. It was twofold higher than in the non-obese
adults (2.97%) and obese children and adolescents (2.46%)
described in our study. If the results presented in both
reports were analyzed together (n=343+311=654), the
incidence of the carriers in the Polish population would
be 4.43%. Our study on the association between both
variants and the RBMI showed that six carriers of the 103L
variant had a similar mean RBMI to that observed for non-
carriers, while two carriers of the 251L variant had a lower
RBMI, but, again, the differences were not significant.
Recently, polymorphisms of other candidate genes for
obesity were studied in the Polish population. Safranow et
al. (2011) analyzed the distribution of mutations in the
AMPD1 (adenosine monophosphate deaminase 1) gene in
Polish patients with cardiovascular diseases and no signifi-
cant associations between four studied polymorphic variants
and the incidence of obesity (BMI>30) were observed.
Another study concerned polymorphisms in the 5′ flanking
MC4R minor variant and its effect on obesity Obese carriers Obese non-carriers
n RBMI n RBMI
127L: obesity-associated 2* 177.5 241 163.5
103I: obesity-protective 6* 163.9 237 163.6
251L: obesity-protective 2 147.0 241 163.7
Total: obesity-protective 8 159.7 235 163.7
112M: neutral 1 167.0 242 163.6
73R: unknown 0 – 243 163.6
215L: unknown 1 166.0 242 163.6
Total: neutral and unknown 2 166.5 241 163.6
Table 2 A comparison of the
RBMI in obese carriers of the
MC4R variants and in obese
non-carriers
*Two patients carried two SNPs
(103I and 127L)
322 J Appl Genetics (2011) 52:319–323regions of three genes encoding adipokines: leptin, adipo-
nectin, and resistin (Cieslak et al. 2011). The authors studied
the same cohort of obese children and adolescents as in the
present study. Altogether, 14 polymorphisms were detected
and, among them, five were sufficiently distributed (minor
allele frequency above 0.2) to study their association with the
RBMI in obese children and adolescents, but none of them
appeared to be associated.
Concluding, our results show for the first time the
distribution of polymorphisms in the entire coding se-
quence of the MC4R gene in a cohort of Polish obese
children and adolescents, as well as in a group of non-obese
adults. Among the six identified non-synonymous variants,
two (K73R and M215L) were considered as novel. The
overall frequency of the missense variants in the obese
patients was quite high (4.1%), but not elevated when
compared with the non-obese adults (6.9%). We assume
that the contribution of the MC4R gene mutations and
polymorphisms to the pathogenesis of obesity in Polish
children and adolescents seems to be low.
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